Auris Medical Holding AG (EARS.OQ)
8 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|48||Chairman of the Board, Chief Executive Officer|
|52||2013||Non-Executive Independent Vice Chairman of the Board|
|2017||Chief Financial Officer|
|2016||Head of Investor Relations and Corporate Communications|
- UPDATE 2-Auris Medical shares plunge as deafness drug trial scrapped
- BRIEF-Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness
- Auris Medical to abandon hearing-loss drug trial
- BRIEF-Auris Medical Reports Q3 Loss Per Share CHF 0.14
- BRIEF-Auris Medical Holding AG files for resale of up to 7.2 mln common shares